Nebivolol improves diastolic dysfunction and myocardial remodeling through reductions in oxidative stress in the transgenic (mRen2) rat.
about
Evaluation and management of patients with heart disease and cancer: cardio-oncologyEndothelial dysfunction in cirrhosis: Role of inflammation and oxidative stressClinical utility of fixed-dose combinations in hypertension: evidence for the potential of nebivolol/valsartan.Gaseous hydrogen sulfide protects against myocardial ischemia-reperfusion injury in mice partially independent from hypometabolismIncrease of cortical cerebral blood flow and further cerebral microcirculatory effects of Serelaxin in a sheep model.Regulation of Overnutrition-Induced Cardiac Inflammatory MechanismsThe roles of beta-adrenergic receptors in tumorigenesis and the possible use of beta-adrenergic blockers for cancer treatment: possible genetic and cell-signaling mechanismsDifferential effects of nebivolol vs. metoprolol on microvascular function in hypertensive humans.Differential effects of nebivolol versus metoprolol on functional sympatholysis in hypertensive humansSalt loading exacerbates diastolic dysfunction and cardiac remodeling in young female Ren2 rats.Reactive oxygen species, vascular Noxs, and hypertension: focus on translational and clinical researchThe role of Beta-adrenergic receptor blockers in Alzheimer's disease: potential genetic and cellular signaling mechanisms.The role of β-adrenergic blockers in Parkinson's disease: possible genetic and cell-signaling mechanisms.Nebivolol and valsartan as a fixed-dose combination for the treatment of hypertension.Insulin and β Adrenergic Receptor Signaling: Crosstalk in Heart.Small dedifferentiated cardiomyocytes bordering on microdomains of fibrosis: evidence for reverse remodeling with assisted recovery.Renin overexpression leads to increased titin-based stiffness contributing to diastolic dysfunction in hypertensive mRen2 rats.The relaxin peptide family - potential future hope for neuroprotective therapy? A short review.Hirudin Protects Ang II-Induced Myocardial Fibroblasts Fibrosis by Inhibiting the Extracellular Signal-Regulated Kinase1/2 (ERK1/2) Pathway
P2860
Q26998273-A0D9BD21-9B0F-4D91-BD04-D47EB25D1AF9Q27023122-FD890808-3B03-46EF-BCCD-6D638B0E5334Q34609451-F86A26EF-7920-4EAE-B37F-8136EBC2D5EEQ34722817-06CC3269-135A-4118-8F2E-138D92F9EFA8Q36073516-302842B5-36BC-4C6C-8501-F8F61ADA9AADQ36206138-F6F64BB3-7B59-4559-875A-D15B38A4BEC3Q36500327-9571F36B-8FBB-4356-8894-74FE2079F9E5Q37139610-D7F4C6D1-2CA1-4B4F-A19C-4545AF09D8E9Q37203118-6803834B-483E-4459-823A-12A7E9AEDD6EQ37325130-B9FBBCE0-E0AB-489B-A2FC-B881B538B130Q37433974-917F67E6-A624-42ED-A0A7-2B4A35639BB6Q38108100-0438C0B8-E326-42C2-A133-FD311ADBFA7CQ38108496-D229001E-A4BB-40BD-8C99-DC96A3C05DDAQ38369464-C0BF743B-F8E3-4DA4-AA51-3E3E19F3B969Q39159635-276A6561-E444-424D-AABF-4A4EEBC624AEQ41906276-B6115DD9-F3D2-4385-94BF-67CA4D0CAAF8Q53127213-B5305931-F84B-4301-ABBA-B2DA99F81D79Q55317785-9E6BC165-40C9-4D0F-991A-6660FFB470E6Q58757711-B753BB13-B747-49BA-9BCE-059B43BDB998
P2860
Nebivolol improves diastolic dysfunction and myocardial remodeling through reductions in oxidative stress in the transgenic (mRen2) rat.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Nebivolol improves diastolic d ...... in the transgenic (mRen2) rat.
@ast
Nebivolol improves diastolic d ...... in the transgenic (mRen2) rat.
@en
type
label
Nebivolol improves diastolic d ...... in the transgenic (mRen2) rat.
@ast
Nebivolol improves diastolic d ...... in the transgenic (mRen2) rat.
@en
prefLabel
Nebivolol improves diastolic d ...... in the transgenic (mRen2) rat.
@ast
Nebivolol improves diastolic d ...... in the transgenic (mRen2) rat.
@en
P2093
P2860
P1476
Nebivolol improves diastolic d ...... in the transgenic (mRen2) rat.
@en
P2093
Adam Whaley-Connell
Carlos M Ferrario
James R Sowers
Javad Habibi
Lakshmi Pulakat
Rukhsana Gul
P2860
P304
P356
10.1152/AJPHEART.01126.2011
P577
2012-03-23T00:00:00Z